Dr. Miranda Hallett supports our patent prosecution practice in the areas of medical devices, biotechnology, and life sciences. Dr. Hallett's research experience includes biochemistry, molecular biology, cell biology and cancer biology, bio-imaging, and chemotherapeutic efficacy testing.
As a National Cancer Institute predoctoral fellow and American Cancer Society postdoctoral fellow, Dr. Hallett researched treatments for breast and colorectal cancers.
Dr. Hallett received her PhD in Cancer and Developmental Biology in 2011 from the University of Tennessee Health Science Center. As a graduate student, her research involved the design of catalytic DNA molecules (DNAzymes) to significantly decrease mammary tumor growth, angiogenesis and increase tumor cell apoptosis.
Before joining the firm, Dr. Hallett completed a postdoctoral fellowship at Vanderbilt University studying factors that affect chemo-resistance in patients with metastatic colorectal cancer.
Dr. Hallett has authored a number of publications and has won numerous awards for her research accomplishments.
- Postdoctoral Fellow, Vanderbilt University Medical Center, 2015
- PhD, Biomedical Science, University of Tennessee Health Science Center, 2011
- BS, Chemistry, Spelman College, 2006
- *Not admitted to the practice of law
- US Patent and Trademark Office